1067 Companies
Aclaris Therapeutics, Inc.: Innovating Therapies for Immune-Inflammatory Diseases Pennsylvania-based Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovati...
Aclaris Therapeutics Annual Report 2023Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company based in Seattle, is making strides in developing medicines that address unmet medical needs in the field of oncology. The comp...
Atossa Therapeutics, Inc. Annual Report 2023Dublin-based clinical research organization ICON Public Limited Company is a leading provider of outsourced development and commercialization services across the globe. The company specializes in t...
ICON Public Company Annual Report 2023ImpediMed Limited is a medical software technology company that specializes in the development, manufacturing, and selling of bioimpedance spectroscopy (BIS) devices and software services. With a p...
ImpediMed Limited Annual Report 2023Cigna Group, a leading provider of insurance and related products and services in the US, is expanding its healthcare offerings through its Evernorth Health Services segment. The segment provides a...
Cell Impact Annual Report 2023Advanz Pharma Corp is a multinational pharmaceutical company dedicated to improving the health of patients worldwide. With a focus on providing high-quality niche medications, Advanz Pharma aims to...
Advanz Pharma Corp Annual Report 2019Aileron Therapeutics, an American company specializing in chemoprotection oncology, is making strides in cancer treatment with its cutting-edge drug, ALRN-6924. The drug is currently undergoing sev...
Aileron Therapeutics, Inc. Annual Report 2023Health care product manufacturer Abbott Laboratories, and its subsidiaries, have a global presence with their offerings of pharmaceuticals, diagnostics, nutritional products, and medical devices. T...
Abbott Laboratories Annual Report 2023Late-stage clinical biopharmaceutical company, SELLAS Life Sciences Group, Inc., is leading the charge in cancer immunotherapy development across various cancer indications in the United States. Th...
SELLAS Life Sciences Group, Inc. Annual Report 2023Therapix Biosciences Ltd. is a clinical-stage pharmaceutical company specializing in cannabinoid pharmaceuticals development. Led by a seasoned team of executives and scientists, the company is foc...
Therapix Biosciences Ltd. Annual Report 2018Sintx Technologies, Inc., a cutting-edge materials firm specializing in the production of medical devices utilizing silicon nitride for a variety of biomedical, industrial, and antipathogenic appli...
SiNtx Technologies, Inc. Annual Report 2023Seattle-based Neoleukin Therapeutics is harnessing protein design technology to develop immunotherapies for cancer, inflammation, and autoimmunity disorders. At the forefront of the company's devel...
Neoleukin Therapeutics Annual Report 2022Canadian cannabis producer HEXO Corp. is making a name for itself in the industry by offering adult-use and medical products under the HEXO brand name. The company is also diversifying its portfoli...
Hexo Annual Report 2021BioXcel Therapeutics, Inc., a biopharmaceutical company that harnesses the power of artificial intelligence to develop revolutionary medicines in neuroscience and immuno-oncology, has made signific...
BioXcel Therapeutics Annual Report 2023Greenlane Holdings Delivers High-Potential Growth through Expanding Cannabis Accessories and Vape Solutions Greenlane Holdings, Inc. is a vibrant player in the cannabis market, specializing in the...
Greenlane Annual Report 2023